Toronto - Delayed Quote CAD

Cronos Group Inc. (CRON.TO)

3.9900 -0.1500 (-3.62%)
At close: May 17 at 4:00 PM EDT
Loading Chart for CRON.TO
DELL
  • Previous Close 4.1400
  • Open 4.1700
  • Bid 3.9400 x --
  • Ask 4.0800 x --
  • Day's Range 3.9400 - 4.2500
  • 52 Week Range 2.1450 - 4.2800
  • Volume 399,194
  • Avg. Volume 277,624
  • Market Cap (intraday) 1.524B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1900
  • Earnings Date Aug 6, 2024 - Aug 12, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 3.98

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

www.thecronosgroup.com

356

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CRON.TO

Performance Overview: CRON.TO

Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CRON.TO
44.04%
S&P/TSX Composite index
7.19%

1-Year Return

CRON.TO
74.24%
S&P/TSX Composite index
10.98%

3-Year Return

CRON.TO
54.71%
S&P/TSX Composite index
16.00%

5-Year Return

CRON.TO
80.54%
S&P/TSX Composite index
36.62%

Compare To: CRON.TO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CRON.TO

Valuation Measures

Annual
As of 5/17/2024
  • Market Cap

    1.52B

  • Enterprise Value

    363.00M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    12.02

  • Price/Book (mrq)

    1.04

  • Enterprise Value/Revenue

    2.87

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -61.31%

  • Return on Assets (ttm)

    -4.02%

  • Return on Equity (ttm)

    -4.99%

  • Revenue (ttm)

    93.03M

  • Net Income Avi to Common (ttm)

    -54.14M

  • Diluted EPS (ttm)

    -0.1900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    855.11M

  • Total Debt/Equity (mrq)

    0.21%

  • Levered Free Cash Flow (ttm)

    -37.6M

Research Analysis: CRON.TO

Company Insights: CRON.TO

Research Reports: CRON.TO

People Also Watch